questionsmedicales.fr
Maladies cardiovasculaires
Maladies vasculaires
Embolie et thrombose
Thromboembolie
Thromboembolisme veineux
Thromboembolisme veineux : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thromboembolisme veineux : Questions médicales les plus fréquentes",
"headline": "Thromboembolisme veineux : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thromboembolisme veineux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-21",
"dateModified": "2025-04-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thromboembolisme veineux"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Thromboembolie",
"url": "https://questionsmedicales.fr/mesh/D013923",
"about": {
"@type": "MedicalCondition",
"name": "Thromboembolie",
"code": {
"@type": "MedicalCode",
"code": "D013923",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.355.590"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Thromboembolisme veineux",
"alternateName": "Venous Thromboembolism",
"code": {
"@type": "MedicalCode",
"code": "D054556",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Jean M Connors",
"url": "https://questionsmedicales.fr/author/Jean%20M%20Connors",
"affiliation": {
"@type": "Organization",
"name": "Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA."
}
},
{
"@type": "Person",
"name": "Francis Couturaud",
"url": "https://questionsmedicales.fr/author/Francis%20Couturaud",
"affiliation": {
"@type": "Organization",
"name": "CHU Brest, Département de Médecine Interne et Pneumologie, Brest, France; Univ_Brest, INSERM U1304-GETBO, CIC INSERM 1412, F29609 Brest; FCRIN INNOVTE network, Saint-Etienne, France. Electronic address: francis.couturaud@chu-brest.fr."
}
},
{
"@type": "Person",
"name": "Susan R Kahn",
"url": "https://questionsmedicales.fr/author/Susan%20R%20Kahn",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, McGill University, Montreal, QC, Canada; Division of Internal Medicine and Division of Clinical Epidemiology, Jewish General Hospital/Lady Davis Institute, Montreal, QC, Canada."
}
},
{
"@type": "Person",
"name": "Marc Blondon",
"url": "https://questionsmedicales.fr/author/Marc%20Blondon",
"affiliation": {
"@type": "Organization",
"name": "Service d'angiologie et d'hémostase, HUG, 1211 Genève 14, et Faculté de médecine, Université de Genève, 1211 Genève 4."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Health risks from radioactive particles on Cumbrian beaches near the Sellafield nuclear site.",
"datePublished": "2023-07-13",
"url": "https://questionsmedicales.fr/article/37339608",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1088/1361-6498/acdfd6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of a stand-alone precalculated Monte Carlo code to calculate the dose by alpha and beta emitters from the Ra-224 decay chain.",
"datePublished": "2023-05-10",
"url": "https://questionsmedicales.fr/article/37161766",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/mp.16446"
}
},
{
"@type": "ScholarlyArticle",
"name": "Alpha-particles induced reactions on",
"datePublished": "2024-10-09",
"url": "https://questionsmedicales.fr/article/39406049",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.apradiso.2024.111544"
}
},
{
"@type": "ScholarlyArticle",
"name": "Small-scale dosimetry for alpha particle",
"datePublished": "2022-07-19",
"url": "https://questionsmedicales.fr/article/35852717",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40658-022-00475-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of an ultrahigh resolution real time alpha particle imaging system for observing the trajectories of alpha particles in a scintillator.",
"datePublished": "2023-04-26",
"url": "https://questionsmedicales.fr/article/37100780",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-31748-9"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies cardiovasculaires",
"item": "https://questionsmedicales.fr/mesh/D002318"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies vasculaires",
"item": "https://questionsmedicales.fr/mesh/D014652"
},
{
"@type": "ListItem",
"position": 4,
"name": "Embolie et thrombose",
"item": "https://questionsmedicales.fr/mesh/D016769"
},
{
"@type": "ListItem",
"position": 5,
"name": "Thromboembolie",
"item": "https://questionsmedicales.fr/mesh/D013923"
},
{
"@type": "ListItem",
"position": 6,
"name": "Thromboembolisme veineux",
"item": "https://questionsmedicales.fr/mesh/D054556"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thromboembolisme veineux - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thromboembolisme veineux",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thromboembolisme veineux",
"description": "Comment diagnostiquer un thromboembolisme veineux ?\nQuels tests sont utilisés pour confirmer un TEV ?\nQuels signes cliniques indiquent un TEV ?\nLe scanner est-il utile pour le TEV ?\nComment évaluer le risque de TEV ?",
"url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Alpha+Particles&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thromboembolisme veineux",
"description": "Quels sont les symptômes d'un TEV ?\nComment se manifeste une embolie pulmonaire ?\nLe TEV peut-il être asymptomatique ?\nQuels signes alertent sur un TEV ?\nLes symptômes varient-ils selon l'emplacement ?",
"url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Alpha+Particles&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thromboembolisme veineux",
"description": "Comment prévenir le TEV ?\nLes bas de compression aident-ils ?\nQuand est-il crucial de prévenir le TEV ?\nLes voyages longs augmentent-ils le risque ?\nL'activité physique réduit-elle le risque ?",
"url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Alpha+Particles&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thromboembolisme veineux",
"description": "Quels traitements sont disponibles pour le TEV ?\nComment fonctionnent les anticoagulants ?\nQuand utiliser la thrombolyse ?\nQuels sont les effets secondaires des anticoagulants ?\nLe traitement préventif est-il nécessaire ?",
"url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Alpha+Particles&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thromboembolisme veineux",
"description": "Quelles sont les complications du TEV ?\nL'embolie pulmonaire est-elle grave ?\nQu'est-ce que le syndrome post-thrombotique ?\nLe TEV peut-il entraîner des problèmes cardiaques ?\nComment gérer les complications du TEV ?",
"url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Alpha+Particles&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thromboembolisme veineux",
"description": "Quels sont les principaux facteurs de risque du TEV ?\nL'âge influence-t-il le risque de TEV ?\nLes femmes enceintes sont-elles à risque ?\nLes antécédents de TEV augmentent-ils le risque ?\nLe tabagisme est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Alpha+Particles&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un thromboembolisme veineux ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation clinique, l'échographie Doppler et les tests sanguins."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer un TEV ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'échographie, le D-dimère et parfois l'angiographie."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent un TEV ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent douleur, œdème, rougeur et chaleur dans la zone affectée."
}
},
{
"@type": "Question",
"name": "Le scanner est-il utile pour le TEV ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le scanner thoracique peut détecter une embolie pulmonaire associée."
}
},
{
"@type": "Question",
"name": "Comment évaluer le risque de TEV ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des scores comme le score de Wells aident à évaluer le risque de TEV."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'un TEV ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur, gonflement, chaleur et rougeur dans la jambe."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une embolie pulmonaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par une douleur thoracique, essoufflement et parfois toux avec sang."
}
},
{
"@type": "Question",
"name": "Le TEV peut-il être asymptomatique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains cas de TEV peuvent ne présenter aucun symptôme visible."
}
},
{
"@type": "Question",
"name": "Quels signes alertent sur un TEV ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un gonflement soudain d'une jambe et une douleur intense sont des signes d'alerte."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'emplacement ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon que le caillot est dans une veine profonde ou pulmonaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir le TEV ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut l'exercice régulier, l'hydratation et l'utilisation d'anticoagulants si nécessaire."
}
},
{
"@type": "Question",
"name": "Les bas de compression aident-ils ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les bas de compression aident à améliorer la circulation sanguine et à prévenir le TEV."
}
},
{
"@type": "Question",
"name": "Quand est-il crucial de prévenir le TEV ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Après une chirurgie ou lors d'une immobilisation prolongée, la prévention est cruciale."
}
},
{
"@type": "Question",
"name": "Les voyages longs augmentent-ils le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages prolongés en position assise augmentent le risque de TEV."
}
},
{
"@type": "Question",
"name": "L'activité physique réduit-elle le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'activité physique régulière aide à réduire le risque de formation de caillots."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le TEV ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les anticoagulants, la thrombolyse et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "Comment fonctionnent les anticoagulants ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils empêchent la formation de nouveaux caillots et aident à dissoudre les existants."
}
},
{
"@type": "Question",
"name": "Quand utiliser la thrombolyse ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thrombolyse est utilisée dans les cas graves d'embolie pulmonaire pour dissoudre rapidement le caillot."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des anticoagulants ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent des saignements, des ecchymoses et des réactions allergiques."
}
},
{
"@type": "Question",
"name": "Le traitement préventif est-il nécessaire ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chez les patients à risque, un traitement préventif est souvent recommandé."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du TEV ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'embolie pulmonaire, l'insuffisance veineuse et le syndrome post-thrombotique."
}
},
{
"@type": "Question",
"name": "L'embolie pulmonaire est-elle grave ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'embolie pulmonaire peut être mortelle et nécessite une attention médicale immédiate."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que le syndrome post-thrombotique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une complication chronique du TEV, entraînant douleur et gonflement persistants."
}
},
{
"@type": "Question",
"name": "Le TEV peut-il entraîner des problèmes cardiaques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une embolie pulmonaire peut provoquer des problèmes cardiaques en surchargeant le cœur."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications du TEV ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut un suivi médical régulier et des traitements adaptés aux complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du TEV ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immobilisation, l'obésité, les antécédents familiaux et certaines maladies."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de TEV ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de TEV augmente avec l'âge, surtout après 60 ans."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la grossesse augmente le risque de TEV en raison des changements hormonaux et de la circulation."
}
},
{
"@type": "Question",
"name": "Les antécédents de TEV augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des antécédents de TEV augmente significativement le risque de récidive."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque de formation de caillots sanguins."
}
}
]
}
]
}
A monitoring programme, in place since 2006, continues to recover radioactive particles (<2 mm diameter) and larger objects from the beaches of West Cumbria. The potential risks to members of the publ...
Recent developments in alpha and beta emitting radionuclide therapy highlight the importance of developing efficient methods for patient-specific dosimetry. Traditional tabulated methods such as Medic...
To implement the PMC method to calculate energy deposited by alpha and beta particles emitted from the Ra-224 decay chain....
The GEANT4 (version 10.7) MC toolkit was used to generate databases of precalculated tracks to be integrated in the PMC code as well as to benchmark its output. In this regard, energy spectra of alpha...
In the case of alpha decay, primary alpha particles show the highest contribution (>99%) in deposited energy compared to their secondary particles. In most cases, protons act as the main secondary par...
The PMC code shows good performance for dose calculations deposited by alpha and beta emitters. As a stand-alone algorithm, it is suitable to be integrated into clinical treatment planning systems....
The development of new targeted alpha therapies motivates improving alpha particle dosimetry. For alpha particles, microscopic targets must be considered to estimate dosimetric quantities that can pre...
A Monte Carlo simulation model of an...
The mesh volume phantom detected a higher mean of alpha particle hits and energy imparted (MeV) per cell nuclei than the elliptical cylinder phantom, but the mean specific energy (Gy) was very similar...
Two methods to generate cell nuclei phantoms for Monte Carlo dosimetry simulations were tested and generated similar results. The simulated and detected RIF distributions from alpha particle-irradiate...
High-resolution imaging of alpha particles is required in the detection of alpha radionuclides in cells or small organs for the development of radio-compounds for targeted alpha-particle therapy or ot...
Alpha-particle discrimination using ultra-thin plastic scintillator sheets for measuring the activity of α-emitters under the existence of α- and β-emitters was investigated....
A neural network was trained to accurately predict the entire single-event specific energy spectra for use in alpha-particle microdosimetry calculations....
The network consisted of 4 inputs and 21 outputs and was trained on data calculated using Monte Carlo simulation where input parameters originated both from previously published data as well as random...
For the final network, the root mean square error (RMSE) values of z...
In summary, the network was able to accurately reproduce alpha-particle single-event spectra for a wide range of source-target geometries....
Diffusing alpha-emitters Radiation Therapy ("DaRT") is a promising new modality for the treatment of solid tumors. Interstitial sources containing...
To date, estimating the dose delivered under the D-L model has been accomplished with numerical solutions based on finite difference methods, namely DART1D and DART2D, as well as with asymptotic expre...
We develop a two-dimensional finite element solution to the D-L model implemented using the FEniCS software library. Our approach solves the variational formulation of the D-L equations on an unstruct...
The local dose at the end of a 30 day treatment period estimated by our numerical method differs from DART1D and DART2D by less than 1% in the source midplane and less than 3% along the source axis ov...
The 2D finite element model reproduces the calculated dose obtained with DART1D and DART2D under the assumptions D-L model. The variation in predicted dose within current experimental ranges for model...
Radiation-hardened semiconductor GaN has drawn considerable attention owing to its excellent properties such as large displacement energy. Many studies have focused on evaluating the degradation of Ga...